[Studies on the fate of 5-fluoro-1,3-bis(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FD-1), a new antitumor agent. I. Absorption, distribution, excretion and metabolism of FD-1 administered orally to rats (author's transl)].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples